Enrollment has reached 50% in an ongoing study testing whether a PET tracer can reliably measure myelin damage in people with ...

A new study from Brigham and Women's Hospital suggests that positron emission tomography (PET) brain scans could reveal hidden inflammation in patients with multiple sclerosis (MS) who are being ...

Stock Gains After Enrollment Milestone Reached Shares of Quantum BioPharma (NASDAQ:QNTM) rose 10% in premarket trading on ...

Researchers at University College London have developed a new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis ...

A study found a twofold higher risk of MS for people with myelitis, or spinal cord inflammation, who have multiple lesions on ...

A recent Npj Digital Medicine study assesses the accuracy and effectiveness of artificial intelligence (AI)-based imaging techniques to diagnose multiple sclerosis (MS). Study: A real-world clinical ...

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that patient enrollment in its collaborative multiple sclerosis ...

The trial includes 48 patients with non-active secondary progressive multiple sclerosis (na-SPMS) across the U.S. ・The ...

CHICAGO (Reuters) - Brain scans using magnetic resonance imaging may be able to detect signs of multiple sclerosis long before symptoms of the disease appear, U.S. researchers said on Wednesday. They ...

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum ...